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Abstract
The retina is one of the major energy consuming tissues within the body. In this context, synaptic transmission between
light-excited rod and cone photoreceptors and downstream ON-bipolar neurons is a highly demanding energy consuming
process. Sirtuin 6 (SIRT6), a NAD-dependent deacylase, plays a key role in regulating glucose metabolism. In this study, we
demonstrate that SIRT6 is highly expressed in the retina, controlling levels of histone H3K9 and H3K56 acetylation. Notably,
despite apparent normal histology, SIRT6 deficiency caused major retinal transmission defects concomitant to changes in
expression of glycolytic genes and glutamate receptors, as well as elevated levels of apoptosis in inner retina cells. Our
results identify SIRT6 as a critical modulator of retinal function, likely through its effects on chromatin.
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Introduction
The mammalian retina is a highly metabolically active tissue
and one of the most energy-consuming ones [1]. It requires
constant supply of blood glucose to sustain its function and its
energy demand is normally met through the uptake of glucose and
oxygen [2,3]. Glucose movement across the blood–retinal barrier
occurs mainly through the glucose transporter 1 (GLUT1) [4,5]
and the need for glucose is evidenced by alterations in
electroretinogram (ERG) responses and altered neurotransmitter
release observed in hypoglycemic conditions [6,7,8]. It has been
shown that acute hypoglycemia decreases rod and cone vision,
blurs central vision, and produces temporary central scotomas in
humans [6,9–11]. The consequence of sustained hypoglycemia on
retinal function is less clear.
Among many neuronal cellular events, action potential-medi-
ated neuronal communication is believed to be a major process of
energy consumption where energy cost comes mainly from
postsynaptic receptor activation [12]. In the brain, most of the
synaptic activity is mediated by glutamate, thus, the excitatory
glutamatergic system represents the single largest energy user,
consuming 50% of ATP in the brain [13].
Photoreceptors convert light stimuli to electric impulses. Retinal
ON bipolar cells receive direct glutamatergic input from
photoreceptor cells. These cells exclusively express the class III
G0-coupled type 6 metabotropic glutamate receptor (mGluR6 or
Grm6) as their primary postsynaptic glutamate receptor [14,15].
Activation of mGluR6 initiates an intracellular signaling cascade
ultimately leading to closure of cGMP gated cation channels and
cell hyperpolarization. Thus, energy requirement and consump-
tion in the retina changes greatly according to neuronal activity
[1].
Sirtuins are an evolutionarily conserved family of NAD+-
dependent deacylases that have been involved in many cellular
responses to stress, including chromatin modifications, genomic
stability, metabolism, inflammation, cellular senescence and
organismal lifespan [16,17,18]. In mammals, 7 sirtuin isoforms
have been described that differ in their subcellular localization and
substrates. It is currently accepted that sirtuins are crucial
regulators of energy metabolism, likely through sensing changes
in levels of intracellular NAD+. Among the members of this family
of proteins, SIRT6 appears to have particular significance in
regulating metabolism, DNA repair and lifespan. SIRT6 knockout
mice appear normal at birth, but they rapidly develop a
degenerative process that includes loss of subcutaneous fat,
lymphopenia, osteopenia, and acute onset of hypoglycemia,
leading to death in less than one month of age [19]. Recently,
Zhong et al. demonstrated that the lethal hypoglycemia exhibited
by SIRT6 deficient mice is caused by an increased in glucose
uptake in muscle and brown adipose tissue [20]. At a molecular
level, SIRT6 functions as a histone H3K9 and H3K56 deacetylase
to control glucose homeostasis by inhibiting multiple glycolytic
genes, including GLUT1, and by co-repressing Hif1a, a critical
regulator of nutrient stress responses [20].
Given the importance of glucose availability for retinal function,
and the critical role of SIRT6 in modulating glycolysis, we
undertook this study to characterize SIRT6 in the mouse retina.
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We found that SIRT6 is expressed and is active in the mouse
retina. SIRT6 deficiency has no effect on retinal structure but KO
mice retinas exhibited up-regulation of the glucose transporter
GLUT1 and down-regulation of the metabotropic glutamate
receptor Grm6, indicating that both neurotransmission and
glucose levels in the retina might be regulated by SIRT6. ERG
analysis showed that the retina of SIRT6-KO mice was
profoundly impaired.
Methods
All animal procedures were in strict accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research. The ethic committee of the School of Medicine,
University of Buenos Aires (Institutional Committee for the Care
and Use of Laboratory Animals, (CICUAL) approved this study.
Unless specified, all experiments were performed with retinas
from 20-day-old mice.
In situ hybridization (ISH)
ISH for Sirt6 transcripts was performed on paraffin-fixed retinas
at the service at the Dana Farber/Harvard Cancer Center (DF/
HCC) specialized histopathology research pathology core using
RNAscope, according to the manufacturer’s instructions.
Morphologic analysis
Anesthetized mice were intracardiacally perfused with 4%
paraformaldehyde as previously described [22]. Eyes were
removed, immersed for 24 h in the same fixative, embedded in
paraffin and sectioned (6 mm). Sections were stained with
hematoxylin and eosin and used for morphometric analysis.
Digital images were obtained at 1 mm dorsal and ventral from the
optic disk. Thickness of the total retina as well as the individual
layers was measured for each eye. Results obtained from four
separate sections were averaged and the mean of 4 eyes was
recorded as the representative value for each group.
RNA Isolation
Retinas were homogenized in phenol-guanidine isothiocyanate
(Invitrogen Life Technologies). RNA was extracted with chloro-
form and precipitated with isopropanol by centrifugation
(12,000 g) at 4uC. The RNA pellet was washed twice with 75%
ethanol and resuspended in 30 mL of water treated with
diethylpyrocarbonate. The concentration and quality of total
RNA samples were assessed using a NANODROP 2000
spectrophotometer (Thermo Scientific Inc., Newark, DE). Only
RNA samples with adequate purity ratios (A260/A280J 1.9–2.1)
were used for subsequent analyses.
qRT-PCR
For qRT-PCR, total RNA was isolated using RNeasy Mini Kit
(QIAGEN) and cDNA was generated using QuantiTect Reverse
Transcription Kit (QIAGEN) according to manufacturer instruc-
tions. qPCR was carried out using Brilliant SYBR Green qPCR
Master Mix Kit (Stratagene). Data were calculated using the DCt
method. Primers used were as follow: Sirt6-F GGGAACTT-
GAAGGAACCACA, Sirt6-R AGCCTGGGCTATAG-
CAGTGA, Glut1-F GCAGTTCGGCTATAACACTGG,
Glut1-R GAGACCAAAGCGTGGTGAGT, Grm6-F
GTCCATCATGGTCGCCAATGT, Grm6-R AGTCA-
TAGCGTGTGGAGTCAC, b-actin-F ACTATTGGCAAC-
GAGCGGTTC, b-actin-R AAGGAAGGCTGGAAAAGAGCC.
RNA expression array
Whole retina mRNA from SIRT6 WT and KO mice (n = 3
from each condition) was hybridized onto an Affymetrix Mouse
Gene 2.1 ST DNA microarrays. Raw expression values in the
form of CEL files were processed and normalized using RMA in
the R Bioconductor package (data used in the analysis is available
in GEO under accession GSE56563). Clustering of the genes of
glutamatergic synapse receptors was performed in R on row-
normalized data using the heatmap.2 function with Euclidean
distance and the complete agglomeration method. When multiple
probe sets were available for a particular gene in a pathway, the
probe set with the maximum variance in the data set was chosen.
Chromatin extraction and Western blot analysis
Western blot analysis was carried out as previously described
[21]. The antibodies used were as follows: anti-SIRT6 (1:1000,
Abcam), anti-AcH3K9 (1:500, Novus Biological), anti-AcH3K56
(1:500, Sigma), anti-Histone 3 (1:1000, Abcam), anti- b-actin
(1:5000, Abcam), anti-Grm6 (1:500, Novus Biologicals), anti-
GLUT1 (1:500, Abcam), horseradish peroxidase-conjugated goat
anti-rabbit (1:2000, catalog # 170-5046; Bio-Rad Laboratories,
Hercules, CA, USA or anti-mouse IgG antibody (1:10000, catalog
# 115-035-146; Jackson ImmunoResearch Laboratories, West
Grove, PA, USA). Briefly, histone enriched extracts were obtained
by homogenizing the retinas in lysis buffer (10 mM Hepes pH 7.4,
10 mM KCl, 0,05% NP-40 plus protease inhibitors (Roche).
Homogenates were kept in ice for 20 min and centrifuged at
14.000 rpm for 10 min at 4uC. Supernatant was used for
cytoplasmic protein determination and pellets were resuspended
in 100 mL of HCl 0,2N. Afer 20 min on ice, samples were
centrifuged at 14.000 rpm for 10 min at 4uC. Supernatants were
separated and neutralized with 1M TRIS-HCl pH 8. An aliquot
was used to determine protein concentration by the Bradford
method. Samples (30 mg protein/well) were separated by 4–20%
gradient Tris-glycine SDS-PAGE pre casted gel (BioRad). Proteins
were transferred to polyvinylidene difluoride (PVDF) membranes,
blocked and incubated with the corresponding primary antibodies
overnight at 4uC. After washing and incubation for 1 h at room
temperature with the indicated secondary antibody they were
visualized by enzymatic chemiluminiscence (ECL, Western
Blotting Analysis System, Amersham Biosciences, Buenos Aires,
Argentina). Developed membranes were scanned and the intensity
of bands was determined by using the ImageJ program (National
Institutes of Health, Bethesda, MD, USA). Values were expressed
as arbitrary units relative to b-actin or total H3.
Immunoflourescence
After deparaffinization, sections were immersed in 0.1% Triton
X-100 in 0.1 M PBS for 10 min. Antigen retrieval was performed
by heating at 90uC for 30 minutes in citrate buffer (pH 6.3).
Sections were pre-incubated with 5% normal horse serum for 1 h,
and incubated overnight at 4uC with the corresponding primary
antibodies. After several washings, sections were incubated with
the corresponding secondary antibody for 1 h at room tempera-
ture (Alexa Fluor 555 Goat Anti-Mouse IgG, 1:500, Alexa Fluor
488 Goat Anti-rabbit IgG, 1:500). Regularly, some sections were
treated without primary antibodies to confirm specificity. After
immunostaining, nuclei were stained with DAPI, mounted with
antifade medium and viewed with a fluorescence microscope as
described.
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TUNEL
The ApopTag Plus Peroxidase In Situ Apoptosis Detection Kit
was use to detect apoptotic cells utilizing terminal deoxynucleo-
tidyl transferase (TdT) specific staining in paraffin embedded
retinal sections according to manufacturer instructions.
Electroretinography (ERG)
Bilateral flash ERG measurements were performed as previ-
ously described [23] using a UTAS-E3000 Visual Electrodiagnos-
tic System running EM for Windows (LKC Technologies, Inc.,
Gaithersburg, MD). Mice (n = 4 for each group) were dark-
adapted overnight and anesthetized with 80 mg/kg ketamine and
15 mg/kg xylazine under dim red illumination for electrode
placement and testing. Body temperature was maintained at
3760.5uC with a heating pad controlled by a rectal temperature
probe (FHC Inc., Bowdoin, ME). The mouse’s head was
positioned just inside the opening of the Ganzfeld dome and
pupils were dilated with 1.0% atropine sulfate (Bausch & Lomb,
Tampa, FL). The recording electrode was a platinum loop 2.0 mm
in diameter, positioned in a drop of 1.25% hydroxypropyl
methylcellulose (GONAK; Akorn Inc., Buffalo Grove, IL) on the
corneal surface of each eye. The reference needle electrode was
inserted under the skin at the vertex of the skull. The ground
Figure 1. SIRT6 is expressed in the mouse retina. A) Representative In situ hybridization showing the expression pattern of SIRT6 in 14-days-old
mice (n = 3). Scale bar, 100 mm. B) Chromatin preparations from WT and KO mice retinas were analyzed by Western blot. b-actin was used as loading
control (n = 4). Intensity of bands was determined by using the ImageJ software and is represented as arbitrary units. ***p,0.001 C) Retinal
histological examination. Representative photographs from H&E stained retinal sections. 20X, scale bar 50 mm from WT and KO. No evident
alterations in retinal morphologic features were observed. D) Quantitative analysis of retinal layers thickness. Ganglion Cell Layer (GCL), Inner
Plexiform Layer (IPL), Inner nuclear Layer (INL) Outer Plexiform Layer (OPL), Outer Nuclear Layer (ONL), Retinal Pigment Epithelium (RPE). Data are the
mean SEM (n= 4). NS, not significant.
doi:10.1371/journal.pone.0098831.g001
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electrode was inserted under the skin of the mouse’s back or tail.
The stimulus (trial) consisted of a brief, full-field flash (10 ms) either
in darkness, or in the presence of dim (30.0 cd/m2) background
illumination after 10 minutes adaptation time to the background
light. The initiation of the flash was taken as time zero. The
response was recorded over 250 ms plus 25 ms of pre-trial
baseline. Responses from several trials were averaged. The
amplitude of the a-wave was measured from the average pre-trial
baseline to the most negative point of the average trace, and the b-
wave amplitude from that point to the highest positive point,
without subtracting oscillatory potentials. The log light intensity
(log [cd*s/m2]) was calculated based on the manufacturer’s
calibrations. The amplitudes (in microvolts) of dark-adapted a-
and b-waves and light-adapted b-waves were measured from the
lowest point of the raw averaged response trace (occurring prior to
50 ms after the flash) to the subsequent highest point (oscillatory
potentials were not subtracted).
Statistical analysis
Quantitative data were expressed as means 6 SEM of values
obtained from the ‘‘n’’ described in each figure. Significance
values were calculated using Student’s t-test and differences were
considered significant at P,0.05.
Results
In order to characterize SIRT6 in the mouse retina, we first
determined the subcellular localization of this sirtuin. The
expression of SIRT6 was analyzed by in situ hybridization.
Characteristic punctuate staining indicative of mRNA expression
was observed in the nuclei of cells in all retinal layers of sirt6+/+
mice (WT) (Fig. 1A). Consistently, in retina extracts from WT
mice abundant protein levels were detected by Western blot,
where the specificity of the antibody was confirmed by absence of
signal in extract from sirt62/2 (KO) mice (Fig 1B). We then
analyzed the structure of the retina in SIRT6 KO mice. The
histological analysis revealed no evidence of structure alteration
and no difference in the thickness of the whole retina or the
individual layers of the KO mice compared to the WT. Moreover,
KO retinas showed no evidence of inflammation or infiltrate cells
(Fig. 1C–D and Fig. S1). Retinal vasculature was analyzed by a
retina fundus image. No alterations were observed and both the
number and caliber of vessels showed no difference between WT
and KO eyes. Moreover, the underlying pigment was observed to
be homogeneous suggesting no obvious retinal pigment epithelial
abnormality in these animals (Fig. S1).
Changes in histone acetylation status can be used as an
indication of the level of activity of a histone deacetylase (HDAC).
We analyzed the level of acetylation of two of the described
substrates of SIRT6: H3K9 and H3K56. Using both immunoflu-
orescence and western blot analysis, we found that both H3K9Ac
and H3K56Ac were significantly increased in retinal chromatin
preparations from KO mice compared to WT mice, indicating
that SIRT6 is active in the mouse retina, and lack of SIRT6 causes
a profound change in those chromatin modifications (Fig. 2 and
Fig. S2).
It has been described that SIRT6 deficiency in mice renders a
phenotype characterized by a profound hypoglycemia [19] and
that SIRT6-dependent deacetylation of histone H3 at lysines 9
and 56 is required for the regulation of genes associated with
glucose metabolism, including GLUT1 [20]. Since this transporter
is the main one responsible for the transport of glucose across the
blood–retinal barrier (BRB) [4,5], we determined GLUT1
expression in WT and KO retinas. In accordance with previous
findings in other tissues [20], GLUT1 was found to be up-
regulated in KO retinas, using immunofluorescence (Fig.3A),
immunoblotting (Fig. 3B) and PCR (Fig. 3C), suggesting that
glucose availability may be altered in this tissue. Up-regulation of
this transporter was evident in all retinal layers and, interestingly,
in inner retinal vessels. Levels of another transporter, GLUT4,
were not affected (data not shown), suggesting that the effect of
SIRT6 is quite specific.
In order to understand at the molecular level how SIRT6 acts in
the retina, we performed a microarray analysis on total retinal
RNA from 15 days-old animals. Among the genes that showed a
significant variation between WT and KO animals, several genes
involved in glutamatergic synapse (Grm4-8 and the kainate/
AMPA-type ionotropic glutamate receptor, GRIK1 and 2) were
found to be significantly downregulated in the retinas of KO mice
(FIG. 4A). It is worth noting that the most significant difference
was found for the metabotropic receptor Grm6, described to be
expressed exclusively in ON bipolar cells. This result was
confirmed by quantitative PCR and immunostaining (Fig 4B–C).
Down-regulation of Grm6 might cause inner retinal neurons to be
exposed to a higher amount of endogenous glutamate that might
result in severe excitotoxic degeneration [24]. Therefore, we
analyzed the presence of apoptotic cells by TUNEL. Notably, a
significant increase of dead cells was observed in the inner nuclear
layer of SIRT6 KO retinas (Fig 4D).
Synaptic transmission is a highly energy demanding process and
multiple molecular events occur during synaptic activation,
including receptor trafficking, signaling, and metabolic processes.
In order to analyze if the changes in gene expression observed
would have a functional consequence we assessed retinal function
by electroretinography (ERG). As shown in Fig. 5, both scotopic
and photopic a- and b-wave amplitudes were severely altered for
all the light intensities analyzed, indicating that absence of SIRT6
profoundly impaired retinal function.
Discussion
The retina is one of the major energy consuming tissues within
the body, maintaining high glucose metabolism for its energetic
needs. Moreover, synaptic transmission is a highly energy
demanding process, therefore the retina evolved mechanisms to
coordinate synaptic activity with glucose homeostasis.
SIRT6 is a member of the sirtuin family of NAD(+)-dependent
deacylases that acts to maintain homeostatic control of glucose
metabolism by repressing a number of enzymes involved in this
process [20]. Although SIRT6 plays a critical role in modulating
bioenergy homeostasis and that metabolic control is essential for
vision, very little is known regarding this enzyme’s involvement in
retinal physiology. In this study, we aimed for the first functional
characterization of SIRT6 in the mouse retina.
Recent studies have shown that SIRT6 is expressed in the
mouse retina and its levels seem to be higher in this tissue
compared to brain, heart, liver or kidney [25]. We confirmed the
presence of SIRT6 in the mouse retina and were able to determine
that it is expressed in all retinal layers. Moreover, SIRT6 was
found to be active in the retina since lack of this enzyme resulted in
significantly increased level of acetylation of two of its described
substrates, H3K9 and H3K56, in KO retinas compared to WT.
Our previous studies demonstrated that SIRT6 deficiency in
mice renders a phenotype characterized by a profound hypogly-
cemia [19] due to increased glucose uptake. Molecularly, SIRT6
deacetylates H3K9 and H3K56, repressing expression of glycolytic
genes, including the glucose transporter GLUT1 [20]. In the
absence of SIRT6, those genes are up-regulated, causing
SIRT6 Modulates Retinal Function
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uncontrolled glucose uptake and a switch towards glycolytic
metabolism. Since GLUT1 is the sole transporter responsible for
the transport of glucose across the blood–retinal barrier (BRB)
[4,5], we focused on this transporter. Indeed, we found that
mRNA and protein levels of GLUT1 were significantly increased
in retinas from SIRT6 KO mice, suggesting a glucose imbalance
in this tissue. It is expected that GLUT1 upregulation would be
accompanied by an increase of glucose availability in the retina
making difficult to explain the defects we observed. On the other
hand, upregulation of GLUT1 could as well indicate a compen-
satory mechanism due to local low levels of glucose since, as we
published, blood glucose is being mostly uptake by skeletal muscle
and adipose tissue in SIRT6 deficient mice [20]. Whether such
chromatin-dependent changes in GLUT1 play a causal role in the
functional defects we observed in the SIRT6 KO retinas remains
to be determined.
Glutamate is the major excitatory neurotransmitter in the
central nervous system, and plays important roles in regulating cell
excitability and synaptic transmission. Multiple molecular events
are coordinated during synaptic activation, including sodium
Figure 2. SIRT6 is active in the mouse retina. a) H3K56 acetylation is shown by immunofluoescence. b) Representative Western blot showing
protein levels of SIRT6 and the acetylation levels of H3K56 and H3K9 in chromatin preparations from WT and KO mice retinas. Total H3 was used for
normalization. c) Quantification of the intensity of bands was determined by using the ImageJ and is represented as arbitrary units. Data are mean 6
SE (n = 6 eyes/group). **p,0.01, ***p,0.001
doi:10.1371/journal.pone.0098831.g002
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pump activity, receptor trafficking, cytoskeletal rearrangements,
signaling, and metabolic processes, making synaptic activity an
energetically costly process [26]. Microarray analysis on total
retinal RNA revealed that several members of the class III of the
metabotropic glutamate receptor family (Grm4–8), and the
kainate/AMPA-type ionotropic glutamate receptor (GRIK1–2),
are down-regulated in retinas from SIRT6 KO mice. Synaptic
transmission between light-excited rod photoreceptors and down-
stream ON-bipolar neurons is indispensable for dim vision in the
mammalian retina. Indeed, disruption of this process leads to
congenital stationary night blindness in human patients [27].
Notably, among the metabotropic receptors analyzed, Grm6 was
found to be the most significantly down-regulated in KO retinas.
Once released from the pre-synapsis, glutamate can bind to
different glutamate receptors on the post-synapsis or can be
removed from the synaptic cleft by high affinity glutamate
transporters located on adjacent neurons and surrounding glial
cells to prevent cell death. The major pathway of glutamate
metabolism consists of glutamate uptake by glutamate transporters
followed by enzymatic conversion of glutamate to non-toxic
glutamine by glutamine synthetase. When a glutamate transporter
is pharmacologically blocked, inner retinal neurons are exposed to
a higher amount of endogenous glutamate, resulting in severe
excitotoxic degeneration [24]. These observations suggest that
glutamate is neurotoxic when the uptake system is impaired rather
than when the release is excessive. Alternatively, impaired
expression of a post-synaptic receptor may contribute to the
accumulation of the neurotransmitter in the inter-synaptic space.
In this context, down-regulation of Grm6 could account for the
increment of glutamate in the inter-synaptic space exerting a toxic
effect that could explain the increase of TUNEL positive cells
(bipolar cells or Mu¨ller cells or both) found in the inner nuclear
Figure 3. GLUT1 is up-regulated in SIRT6-KO retina. a) GLUTl immunoreactivity in cross-section of WT and SIRT6-KO mice retina. Ganglion Cell
Layer (GCL), Inner Plexiform Layer (IPL), Inner nuclear Layer (INL) Outer Plexiform Layer (OPL), Outer Nuclear Layer (ONL), Retinal Pigment Epithelium
(RPE). GLUT1 protein (b) and mRNA levels (c) were determined by Western blot and RT-PCR respectively. b-actin was used as loading control. Data are
mean 6 SE (n = 6 eyes/group) **p,0.01
doi:10.1371/journal.pone.0098831.g003
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layer of SIRT6 KO retinas. Since both bipolar and Mu¨ller cells
are involved in the generation of the b-wave, apoptotic cells in the
inner nuclear layer would explain the alteration observed in the
ERG.
Although no structural differences were observed between WT
and KO retinas, functional analysis showed a significantly
impaired ERG in KO animals where both a and b waves were
severely compromised. Interestingly, cones would be less affected
than rods since the fold decrease of the a-wave amplitude in the
photopic ERG is less than the fold decrease in the scotopic ERG
(2.5 vs. 8). Whether lack of SIRT6 is affecting photoreceptor
activity specifically requires further studies. Taken together, up-
regulation of GLUT1, down-regulation of Grm6 and the
increased number of apoptotic cells in retinas from sirt62/2 mice
could account, at least in part, for the visual deficiency observed in
these mice.
Overall, our studies demonstrated that SIRT6 deficiency causes
major chromatin changes in the retina, which is accompanied by
marked changes in expression of metabolic genes and metabotro-
pic receptors, likely explaining the severe functional impairment
observed in the SIRT6-KO retinas. Previous studies established
sirtuins as critical modulators of metabolism, protecting against
metabolic- and age-related diseases, such as diabetes, metabolic
syndrome, cancer and neurodegenerative disorders [28]. Our
results indicate that SIRT6 plays an important role in maintaining
normal retinal function.
Altered methylation patterns and histone modifications have
been identified in different ocular diseases like diabetic retinop-
Figure 4. Grm6 is down-regulated in SIRT6-KO retinas.Whole retina mRNA from WT and KO mice was used to profile the expression of several
key genes of glutamate receptors involved in the synaptic transmission in an Affymetrix Mouse Gene 2.1 ST DNA microarray. a) Heatmap representing
the hierarchical cluster analysis shows the differential expressed mRNAs between WT and SIRT6 KO retinas. The graphic depicts the expression levels
of ionotropic AMPA glutamate receptors (Gria1–4), Glutamate receptor, ionotropic kainate (Grik1-2-4-5), Glutamate [NMDA] receptors (Grin1-2a-c)
and metabotropic glutamate receptors (Grm1–8). The expression data for the hierarchical clustering image has been row normalized to a range of
zero to one with blue representing the row minimum and red representing the row maximum. b) RNA was purified from SIRT6 WT and KO retinas,
and Grm6 levels analyzed by RT-PCR. c) immunofluorescence was performed in SIRT6 WT and KO retinas with the indicated antibodies. PKC-alpha was
used as a marker for ON bipolar cells. Ganglion Cell Layer (GCL), Inner Plexiform Layer (IPL), Inner nuclear Layer (INL), Outer Plexiform Layer (OPL),
Outer Nuclear Layer (ONL), Retinal Pigment Epithelium (RPE). Data are mean 6 SE (n = 4) **p,0.01 d) Representative fluorescent images of TUNEL
analysis performed in WT and SIRT6 KO retinal sections. Apoptotic nuclei (bright green dots) labeled with fluorescein-dUTP were visualized by
fluorescence microscopy. Data are mean 6 SE (n = 3) **p,0.01
doi:10.1371/journal.pone.0098831.g004
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athy, glaucoma and age-related macular degeneration [29,30,31].
However, a comprehensively characterized epigenomic signature
for any ocular disease remains elusive. Several questions arise: is
there any epigenetic mark that would predict the onset or the
progression of an ocular disease? Do epigenetic factors regulate
other cellular pathways (other that glucose metabolism and
glutamatergic synapse) that may alter visual function? Although
epigenetic therapies have proven to be effective in cancer
applications [32], the benefits of these approaches have not yet
been applied for human ophthalmic diseases.
Supporting Information
Figure S1 Histological analysis and eye fundus. a)
Representative low magnification (4X) cross-sections of eyes from
WT and SIRT6KO mice. General structure, size and optic nerve
head can be observed. No distinctive alteration is detected in
SIRT6KO retinas b) Representative fundus images were taken
from WT and 2-week-old mouse using the endoscopic fundus
imaging system. Posterior pole of the fundus can be observed.
(TIF)
Figure S2 H3K9 acetylation is shown by immunofluoes-
cence. Ganglion Cell Layer (GCL), Inner Plexiform
Layer (IPL), Inner nuclear Layer (INL) Outer Plexiform
Layer (OPL), Outer Nuclear Layer (ONL), Retinal
Pigment Epithelium (RPE).
(TIF)
File S1 Supporting Methodology.
(DOCX)
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